Tyrosine hydroxylase

From WikiMD's WELLNESSPEDIA

The conversion of tyrosine to L-DOPA by tyrosine hydroxylase.

Tyrosine hydroxylase is an enzyme that is crucial in the biosynthesis of catecholamines. It catalyzes the conversion of the amino acid tyrosine to L-DOPA, which is the precursor to important neurotransmitters such as dopamine, norepinephrine, and epinephrine.

Structure[edit]

Structure of tyrosine hydroxylase from rat, showing two of its domains.

Tyrosine hydroxylase is a tetrameric enzyme, meaning it is composed of four subunits. Each subunit contains a catalytic domain and a regulatory domain. The enzyme requires a cofactor, tetrahydrobiopterin, and molecular oxygen to function. The catalytic domain is responsible for the hydroxylation of tyrosine, while the regulatory domain modulates the enzyme's activity.

Function[edit]

Tyrosine hydroxylase is the rate-limiting enzyme in the synthesis of catecholamines. It is primarily found in the central nervous system, particularly in the substantia nigra and locus coeruleus, as well as in the adrenal medulla. The enzyme's activity is regulated by various factors, including phosphorylation and feedback inhibition by catecholamines.

Clinical Significance[edit]

Dysregulation of tyrosine hydroxylase activity is associated with several neurological disorders. For instance, reduced activity of the enzyme can lead to dopamine deficiency, contributing to conditions such as Parkinson's disease. Conversely, overactivity may be involved in hypertension due to excessive production of norepinephrine.

Research and Applications[edit]

Immunofluorescence image showing serotonin transporter in green, tyrosine hydroxylase in red, and nuclear DNA in blue in a region of rat brain.

Research on tyrosine hydroxylase has provided insights into the treatment of neurological disorders. Inhibitors of the enzyme are being explored as potential therapeutic agents for conditions characterized by excessive catecholamine production. Additionally, understanding the regulation of tyrosine hydroxylase can aid in developing strategies to enhance dopamine production in neurodegenerative diseases.

Related Pages[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.